These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34797317)

  • 1. LKB1 expression and the prognosis of lung cancer: A meta-analysis.
    Lin C; Lin X; Lin K; Tan J; Wei C; Liu T
    Medicine (Baltimore); 2021 Nov; 100(46):e27841. PubMed ID: 34797317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between LKB1 expression and prognosis of patients with solid tumours: an updated systematic review and meta-analysis.
    Ren YH; Zhao FJ; Mo HY; Jia RR; Tang J; Zhao XH; Wei JL; Huo RR; Li QQ; You XM
    BMJ Open; 2019 Aug; 9(8):e027185. PubMed ID: 31383697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and clinicopathological value of PD-L2 in lung cancer: A meta-analysis.
    Lin X; Lin K; Lin C; Liu T; Ba M; Tang Y; Wang J; Zhou L; Wang J; Xiao C
    Int Immunopharmacol; 2021 Feb; 91():107280. PubMed ID: 33370681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.
    Xiao J; Zou Y; Chen X; Gao Y; Xie M; Lu X; Li W; He B; He S; You S; Chen Q
    PLoS One; 2016; 11(4):e0152674. PubMed ID: 27035914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and prognostic significance of LKB1 expression in gastric cancer: a systematic review and meta-analysis.
    Tan G; Liu B
    Sci Rep; 2023 Jun; 13(1):8937. PubMed ID: 37264076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
    Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
    Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer.
    Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K
    Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in
    West HJ; McCleland M; Cappuzzo F; Reck M; Mok TS; Jotte RM; Nishio M; Kim E; Morris S; Zou W; Shames D; Das Thakur M; Shankar G; Socinski MA
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35190375
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Sitthideatphaiboon P; Galan-Cobo A; Negrao MV; Qu X; Poteete A; Zhang F; Liu DD; Lewis WE; Kemp HN; Lewis J; Rinsurongkawong W; Giri U; Lee JJ; Zhang J; Roth JA; Swisher S; Heymach JV
    Clin Cancer Res; 2021 Mar; 27(6):1720-1733. PubMed ID: 33323404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of octamer binding transcription factor 4 for patients with solid tumors: A meta-analysis.
    Zhao X; Lu H; Sun Y; Liu L; Wang H
    Medicine (Baltimore); 2020 Oct; 99(42):e22804. PubMed ID: 33080755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LKB1/STK11 Expression in Lung Adenocarcinoma and Associations With Patterns of Recurrence.
    Mitchell KG; Parra ER; Zhang J; Nelson DB; Corsini EM; Villalobos P; Moran CA; Skoulidis F; Wistuba II; Fujimoto J; Roth JA; Antonoff MB;
    Ann Thorac Surg; 2020 Oct; 110(4):1131-1138. PubMed ID: 32442617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance and prognostic value of E-cadherin expression in non-small cell lung cancer: A protocol for systematic review and meta-analysis.
    Chao D; Hu G; Li Q
    Medicine (Baltimore); 2021 Feb; 100(7):e24748. PubMed ID: 33607820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircRNAs as promising biomarker in diagnostic and prognostic of lung cancer: An updated meta-analysis.
    Yang X; Tian W; Wang S; Ji X; Zhou B
    Genomics; 2021 Jan; 113(1 Pt 1):387-397. PubMed ID: 33326833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis.
    Jiang AM; Zheng HR; Liu N; Zhao R; Ma YY; Bai SH; Tian T; Liang X; Ruan ZP; Fu X; Yao Y
    Cancer Control; 2021; 28():10732748211050581. PubMed ID: 34654345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC00511 as a prognostic biomarker for human cancers: a systematic review and meta-analysis.
    Agbana YL; Abi ME; Ni Y; Xiong G; Chen J; Yun F; Yi Z; Zhang Q; Yang Z; Kuang Y; Zhu Y
    BMC Cancer; 2020 Jul; 20(1):682. PubMed ID: 32698787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic liver kinase B1 promotes the growth of human lung adenocarcinoma by enhancing autophagy.
    Liu M; Jiang L; Fu X; Wang W; Ma J; Tian T; Nan K; Liang X
    Cancer Sci; 2018 Oct; 109(10):3055-3067. PubMed ID: 30033530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis.
    Shao C; Yang F; Qin Z; Jing X; Shu Y; Shen H
    BMC Cancer; 2019 Nov; 19(1):1103. PubMed ID: 31727002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma.
    Çeliktas M; Tanaka I; Tripathi SC; Fahrmann JF; Aguilar-Bonavides C; Villalobos P; Delgado O; Dhillon D; Dennison JB; Ostrin EJ; Wang H; Behrens C; Do KA; Gazdar AF; Hanash SM; Taguchi A
    J Natl Cancer Inst; 2017 Mar; 109(3):1-9. PubMed ID: 28376202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prognostic and Clinicopathologic Characteristics of OCT4 and Lung Cancer: A Meta-Analysis.
    Li H; Wang L; Shi S; Xu Y; Dai X; Li H; Wang J; Zhang Q; Wang Y; Sun S; Li Y
    Curr Mol Med; 2019; 19(1):54-75. PubMed ID: 30854966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and Prognostic Significance of CBX3 Expression in Human Cancer: a Systematic Review and Meta-analysis.
    Lin H; Zhao X; Xia L; Lian J; You J
    Dis Markers; 2020; 2020():2412741. PubMed ID: 33273987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.